Dr Reddys Laboratories (RDY) Total Liabilities (2012 - 2026)

Dr Reddys Laboratories' Total Liabilities history runs 15 years deep, the most recent figure standing at $2.2 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 20.91% year-over-year to $2.2 billion; the TTM figure through Mar 2026 stood at $2.2 billion (up 20.91% YoY), while the FY2026 annual figure was $2.1 billion, up 16.22% from the prior year.
• Total Liabilities was $2.2 billion for Q1 2026 at Dr Reddys Laboratories, up from $2.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.2 billion in Q1 2026 to a low of $1.1 billion in Q3 2022.
• Historically, Total Liabilities has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities retreated 18.75% in 2023, then surged 64.61% in 2024.
• A 5-year view of Total Liabilities shows it stood at $1.1 billion in 2022, then climbed by 6.9% to $1.1 billion in 2023, then soared by 64.61% to $1.9 billion in 2024, then climbed by 10.27% to $2.1 billion in 2025, then advanced by 5.47% to $2.2 billion in 2026.
• The last three Total Liabilities figures came in at $2.2 billion (Q1 2026), $2.1 billion (Q3 2025), and $1.8 billion (Q1 2025), per Business Quant data.